Recruiting studies: Active Juvenile Psoriatic Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744 Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · 45 location(s) · Amgen · NCT04804553 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551 An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Acti
Phase 3 · 23 location(s) · UCB Biopharma SRL · NCT06668181

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.